Explore Our Network

Explore MTEC's network of innovators, investors, and research organizations—along with patents and funding opportunities—advancing medical technologies for military and civilian health.

Showing 6 Patents
Recombinant virus with codon-pair deoptimized region and uses thereof for the treatment of cancer

31-12-2024 • US-12178869-B2

COLEMAN, JOHN ROBERT • MUELLER, STEFFEN • YANG, CHEN • WANG, YING • STAUFT, CHARLES

Codagenix Inc

Attenuated flaviviruses

17-12-2024 • US-12168049-B2

COLEMAN, JOHN ROBERT • MUELLER, STEFFEN • WANG, YING

Codagenix Inc

Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes

06-08-2024 • US-12054519-B2

LE NOUEN, CYRIL • BUCHHOLZ, URSULA J. • COLLINS, PETER L. • MUELLER, STEFFEN

Codagenix Inc • United States Department of Health and Human Services

Live attenuated strains of foot and mouth disease modified by deoptimization and uses thereof

24-10-2023 • US-11793870-B2

DE LOS SANTOS, TERESA B. • RIEDER, AIDA E. • DIAZ-SAN SEGUNDO, FAYNA C. • KLOC, ANNA • COLEMAN, JOHN R. • MUELLER, STEFFEN • MEDINA, GISSELLE N.

United States Department of Agriculture • Codagenix Inc

Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes

19-07-2022 • US-11390651-B2

LENOUEN, CYRIL • BUCHHOLZ, URSULA J. • COLLINS, PETER L. • MUELLER, STEFFEN

Usa Secretary Dhhs • Codagenix Inc • United States Department of Health and Human Services

Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes

20-10-2020 • US-10808012-B2

LENOUEN, CYRIL • BUCHHOLZ, URSULA J. • COLLINS, PETER L. • MUELLER, STEFFEN

Codagenix Inc • United States Department of Health and Human Services

Owner
Inventors
Assignee
Patent Type
Publication Year

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.